vCJD and the gut: Implications for endoscopy

Gut

Volumn 56, Issue 1, 2007, Pages 9-11

  Head, M W ^a   Ironside, J W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

BOVINE SPONGIFORM ENCEPHALOPATHY AGENT; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; GASTROINTESTINAL ENDOSCOPY; HUMAN; INCUBATION TIME; MUTATION; NOTE; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VIRUS TRANSMISSION;

CREUTZFELDT-JAKOB SYNDROME; DIGESTIVE SYSTEM; ENDOSCOPY, GASTROINTESTINAL; GREAT BRITAIN; HUMANS; PREVALENCE; PRION DISEASES; PRIONS;

EID: 33846005089     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.101964     Document Type: Note

References (30)

1. Taylor DM. Inactivation of the unconventional agents of scrapie, bovine spongiform encephalopathy and Creutzfeldt-Jakob disease. J Hosp Infect 1991;18:141-6.
2. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-5.
3. Bruce ME, McConnell I, Will RG, et al. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 2001;358:208-9.
4. Collinge J, Sidle KC, Meads J, et al. Molecular analysis of prion strains variation and the aetiology of 'new variant' CJD. Nature 1996;383:685-90.
5. Scott MR, Will R, Ironside J, et al. Compelling transgenic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci USA, 1999;96:15137-42.
6. Ward HJT, Everington D, Couson SN, et al. Risk factors for variant Creutzfeldt-Jakob disease: a case control study. Ann Neurol 2006;59:111-20.
7. Prusiner SB, Prions. Proc Natl Acad Sci USA, 1998;95:13363-83.
8. Wadsworth JDF, Joiner S, Hill AF, et al. Tissue distribution of protease-resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001;358:171-80.
9. Head MW, Ritchie D, Smith N, et al. Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, qautitative and biochemical study. Am J Pathol 2004;164:143-53.
10. Hilton DA, Ghani AC, Conyers L, et al. Accumulation of prion protein in tonsil and appendix: review of tissue samples. BMJ 2002;325:633-4.
11. Hilton DA, Ghani AC, Conyers L, et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004;203:733-9.
12. Peden AH, Head MW, Ritchie DR, et al. Preclinical vCID after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364:527-9.
13. Ironside JW, Bishop MT, Connolly K, et al. Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix samples from a retrospective prevalence study. BMJ 2006;332:1186- 8.
14. Llewelyn CA, Hewitt PE, Knight RSG, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transmission. Lancet 2004;363:417-21.
15. Wadsworth JDF, Joiner S, Fox K, et al. Prion infectivity in vCJD rectum. Gut 2007;56:90-4.
16. Hill AF, Zeidler M, Ironside JW, et al. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997;349:99-100.
17. Hill AF, Butterworth RJ, Joiner S, et al. Investigating variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999;353:183-9.
18. Joiner S, Lineham JM, Brandner S, et al. High levels of disease related prion protein in the ileum in variant Creutzfeldt-Jakob disease. Gut 2005;54:1506-8.
19. Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997;389:498-501.
20. Jeffrey M, Gonzalez L, Espenes A, et al. Transportation of prion protein across the intestinal mucosa of scrapie-susceptible and scrapie-resistant sheep. J Pathol 2006;209:4-14.
21. St. Rose SG, Hunter N, Matthews L, et al. Comparative evidence for a link between Peyer's patch development and susceptibility to transmissible spongiform encephalopathies. BMC Infect Dis 2006;6:5.
22. Brown P, Cervenakova L, McShane P, et al. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease. Transfusion 1999;39:1169-78.
23. Eglin RP, Murphy WG. Beyond leukodepletion: removing infectious prions by filtration. Transfusion 2005;45:1836-8.
24. Ludlam CA, Turner ML. Managing the risk of transmission of variant Creutzfeldt-Jakob disease by blood products. Br J Haematol 2005;132:13-24.
25. Houston F, Foster JD, Chong A, et al. Transmission of BSE by blood transfusion. Lancet 2000;356:999-1000.
26. Hunter N, Foster J, Chong A, et al. Transmission of prion diseases by blood transfusion. J Gen Virol 2002;83:2897-905.
27. Siso S, Gonzalez L, Houston F, et al. The neuropathological phenotype of experimental ovine BSE is maintained after blood transfusion. Blood, 2006;108,745-8.
28. Baxter HC, Campbell GA, Whittaker AG, et al. Elimination of transmissible spongiform encephalopathy infectivity and decontamination of surgical instruments by using radio-frequency gas-plasma treatment. J Gen Virol 2005;86:2393-9.
29. Fichet G, Comoy E, Duval C, et al. Novel methods for disinfection of prion-contaminated medical devices. Lancet 2004;364:521-6.
30. Pertez D, Supattapone S, Giles K, et al. Inactivation of prions by sodium dodecyl sulfate. J Virol 2006;80:322-31.